The Impact of Meal Frequency on Bone Remodeling in Healthy Adults - Trial NCT06359483
Access comprehensive clinical trial information for NCT06359483 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Jordan and is currently Completed. The study focuses on Healthy Adults. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Jordan
Timeline & Enrollment
N/A
Jun 19, 2021
Jul 04, 2021
Primary Outcome
The title of the primary outcome is Procollagen Type 1 N-terminal propeptide (P1NP) Levels.
Summary
The study aimed to investigate the effect of meal frequency on bone remodeling using the
 marker Procollagen Type 1 N-terminal propeptide (P1NP). Thirty healthy adult males from
 Jordan participated in a randomized controlled intervention trial. They were randomly
 assigned to three or eight daily meals for three consecutive days over two phases. Blood
 samples were obtained at the beginning and end of each phase, and P1NP levels were analyzed.
 The results showed a substantial drop in P1NP levels compared to the baseline, indicating
 that meal frequency influences bone development. There were no significant changes between
 the groups eating three and eight meals per day. The study emphasizes the importance of
 dietary patterns in bone health and advises additional research to understand the
 relationship between meal frequency and bone metabolism.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06359483
Non-Device Trial